Bluejay Diagnostics, Inc. Impairment of Long-Lived Assets Held-for-use
Bluejay Diagnostics, Inc. (BJDX) reported Impairment of Long-Lived Assets Held-for-use of $237.31 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2024-03-28
- Bluejay Diagnostics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2022-12-31 was $27.19K.
- Bluejay Diagnostics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2022-09-30 was $210.12K.
- Bluejay Diagnostics, Inc. impairment of long-lived assets held-for-use for fiscal 2022 was $237.31K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2022-12-31 | $27.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $237.31K derived: sum of 2 quarters · filed 2024-03-28 | $237.31K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $210.12K 10-Q · filed 2022-11-09 | $210.12K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |